Gated chimeric antigen receptor T-cells: The next logical step in reducing toxicity?

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

419 Downloads (Pure)

Original language	English
Pages (from-to)	S61-S65
Journal	Translational Lung Cancer Research
Volume	5
Issue number	S1
DOIs	https://doi.org/10.21037/tcr.2016.06.04
Publication status	Published - 1 Jun 2016

Access to Document

@article{3975d2ff58484716ad1842f77cd40d8d,

title = "Gated chimeric antigen receptor T-cells: The next logical step in reducing toxicity?",

author = "Davies, {David Marc} and John Maher",

year = "2016",

month = jun,

day = "1",

doi = "10.21037/tcr.2016.06.04",

language = "English",

volume = "5",

pages = "S61--S65",

journal = "Translational Lung Cancer Research",

issn = "2218-676X",

publisher = "Society for Translational Medicine (STM)",

number = "S1",

}

TY - JOUR

T1 - Gated chimeric antigen receptor T-cells

T2 - The next logical step in reducing toxicity?

AU - Davies, David Marc

AU - Maher, John

PY - 2016/6/1

Y1 - 2016/6/1

U2 - 10.21037/tcr.2016.06.04

DO - 10.21037/tcr.2016.06.04

M3 - Article

SN - 2218-676X

VL - 5

SP - S61-S65

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

IS - S1

ER -